טוען...
Heart Transplant Survival Outcomes for Adriamycin Dilated Cardiomyopathy
In 2015 there will be an estimated 11.3 million cancer survivors. With a growing population of cancer survivors, it is imperative to understand treatment options and outcomes for chemotherapy related cardiomyopathy. Anthracycline (AC) based chemotherapy causes heart failure (HF) in approximately 5%...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563750/ https://ncbi.nlm.nih.gov/pubmed/23195041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2012.10.048 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|